Farmacias del Ahorro to Grow 56% via Benavides Acquisition

Farmacias del Ahorro announced on Friday a definitive agreement to acquire Farmacias Benavides from its majority shareholder, The Boots Group.

The consolidation will add 1,132 locations to the purchasing chain, expanding its total footprint to over 3,000 units and marking a major shift in the Mexican retail pharmacy sector.

Strategic Consolidation of Retail Pharmacy

  • Farmacias del Ahorro will increase its total market presence by 56% through the acquisition of the 1,132-unit Farmacias Benavides network, as reported by El Norte.
  • The deal brings Benavides—a firm previously under foreign control—back into local ownership, uniting two highly complementary service models under the Comercializadora Farmacéutica de Chiapas structure.
  • The transaction remains subject to customary closing conditions and requires formal authorization from the Comisión Nacional Antimonopolio (CNA), according to El País.

Infrastructure Integration and Market Scale

The merger combines Farmacias del Ahorro’s existing 2,000 locations with the 1,132 stores operated by Benavides. This integration creates a powerhouse with more than 3,000 points of sale, according to El País.

Farmacias del Ahorro reaches 3,000 branches after acquiring Farmacias Benavides — MILENIO

Benavides contributes a robust network, particularly in the northern, eastern, and central regions of Mexico, alongside 450 primary care clinics. Farmacias del Ahorro brings its own established vertical, which currently manages over one million free medical consultations per month and 800,000 home deliveries, as noted by El País.

Metric Farmacias del Ahorro (Pre-Deal) Farmacias Benavides (Pre-Deal)
Medical Clinics Internal Model 450
Q3 2026 Sales Growth N/A 15% YoY

Sales Growth Driven by GLP-1 Medication Demand

The acquisition comes as Farmacias Benavides reported total sales of 5.625 billion pesos (approximately 302 million dollars) for the third quarter of 2026, a 15% increase compared to the same period in 2025. El País reported that this growth was driven largely by the rising demand for GLP-1 medications used in diabetes and obesity treatment.

Farmacias del Ahorro to Grow 56% via Benavides Acquisition
Photo: Yahoo

The competitive landscape is dominated by large-scale players, most notably Farmacias Similares, which operates at least 9,600 establishments across Mexico and Chile.

La adquisición de Farmacias Benavides por parte de Farmacias del Ahorro busca unir a dos proveedores de servicios farmacéuticos y de salud para ampliar su presencia en un mercado donde las empresas integran comercio minorista, atención médica y servicios financieros, como el programa Monedero del Ahorro.

“During more than 100 years, Benavides has been built on the basis of trust and care, and in Farmacias del Ahorro we have found a partner that shares those values,” said Mauricio González, director general of Farmacias Benavides.

Farmacias Benavides vendida: ¿desaparece la marca? — NotiZAS News

Companies Maintain Independent Operations Pending Regulatory Approval

The financial terms of the deal were not disclosed by the parties. The Boots Group, which is majority-owned by Sycamore Partners in association with Stefano Pessina and his family, held a 96.56% stake in the chain since its 2005 acquisition, El País reported. Until regulatory approval is finalized, both companies have committed to maintaining independent operations in the ordinary course of business.

“The integration will allow us to take advantage of the capabilities of both organizations to expand our coverage,” said Rafael Selvas Silva, director general of Farmacias del Ahorro.

Farmacias ahorro compra benavides
Photo: EL CEO
Photo of author

Daniel Foster - Senior Editor, Economy

Senior Editor, Economy An award-winning financial journalist and analyst, Daniel brings sharp insight to economic trends, markets, and policy shifts. He is recognized for breaking complex topics into clear, actionable reports for readers and investors alike.

Gilmore Girls Revival Leaving Netflix on Nov. 25, 2026

Early Dupilumab for EoE Linked to Reduced Asthma Risk in Children